318 related articles for article (PubMed ID: 22327732)
1. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study.
Moosaie F; Davatgari RM; Firouzabadi FD; Esteghamati S; Deravi N; Meysamie A; Khaloo P; Nakhjavani M; Esteghamati A
Can J Diabetes; 2020 Jul; 44(5):414-421. PubMed ID: 32205075
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Serum Apolipoproteins and Traditional Lipids in Eyes with Diabetic Retinopathy in Indian Population: A Case Series.
Prakash G; Agrawal R; Satsangi SK; Prakash S
Middle East Afr J Ophthalmol; 2016; 23(2):212-4. PubMed ID: 27162455
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the serum apolipoprotein ratio to diabetic retinopathy.
Deguchi Y; Maeno T; Saishin Y; Hori Y; Shiba T; Takahashi M
Jpn J Ophthalmol; 2011 Mar; 55(2):128-31. PubMed ID: 21400057
[TBL] [Abstract][Full Text] [Related]
5. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.
Sasongko MB; Wong TY; Nguyen TT; Kawasaki R; Jenkins A; Shaw J; Wang JJ
Diabetes Care; 2011 Feb; 34(2):474-9. PubMed ID: 21270203
[TBL] [Abstract][Full Text] [Related]
6. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
[TBL] [Abstract][Full Text] [Related]
7. [Blood sugar and lipid metabolism parameters in diabetic retinopathy].
Schmut O; Fellinger C; Hofmann H
Klin Monbl Augenheilkd; 1985 May; 186(5):347-50. PubMed ID: 3927059
[TBL] [Abstract][Full Text] [Related]
8. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
[TBL] [Abstract][Full Text] [Related]
9. Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.
Lee JH; Kang HJ; Kim HS; Sohn DW; Oh BH; Park YB
Am J Cardiovasc Drugs; 2013 Oct; 13(5):343-51. PubMed ID: 23728830
[TBL] [Abstract][Full Text] [Related]
10. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
11. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.
Kim SW; Jee JH; Kim HJ; Jin SM; Suh S; Bae JC; Kim SW; Chung JH; Min YK; Lee MS; Lee MK; Kim KW; Kim JH
Int J Cardiol; 2013 Oct; 168(3):2678-83. PubMed ID: 23545148
[TBL] [Abstract][Full Text] [Related]
12. Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus.
Wang JB; Zhang YJ; Zhang Y; Guan J; Chen LY; Fu CH; Du HJ; Sheng Y; Zhou L; Si YF; Zhang Y
Acta Diabetol; 2013 Apr; 50(2):111-5. PubMed ID: 20683626
[TBL] [Abstract][Full Text] [Related]
13. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
[TBL] [Abstract][Full Text] [Related]
14. Association of Spicy Food Consumption Frequency with Serum Lipid Profiles in Older People in China.
Yu K; Xue Y; He T; Guan L; Zhao A; Zhang Y
J Nutr Health Aging; 2018; 22(3):311-320. PubMed ID: 29484343
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.
Păunică I; Mihai AD; Ștefan S; Pantea-Stoian A; Serafinceanu C
J Diabetes Complications; 2023 Dec; 37(12):108634. PubMed ID: 37918178
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study.
Gao L; Zhang Y; Wang X; Dong H
BMC Endocr Disord; 2021 Apr; 21(1):59. PubMed ID: 33794863
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.
Florvall G; Basu S; Larsson A
J Gerontol A Biol Sci Med Sci; 2006 Dec; 61(12):1262-6. PubMed ID: 17234819
[TBL] [Abstract][Full Text] [Related]
20. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.
Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W
J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
